Characterization of the effects of adenosine kinase inhibitors on acute thermal nociception in mice

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 1, 1999, Pages 83-91

  Kowaluk, Elizabeth A ^a   Kohlhaas, Kathy L ^a   Bannon, Anthony ^a   Gunther, Karen ^a   Lynch III, James J ^a   Jarvis, Michael F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Adenosine; Adenosine kinase; Analgesia; Hot plate; Nociception

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 IODOTUBERCIDIN; 5' AMINO 5' DEOXYADENOSINE; 5' DEOXY 5 IODOTUBERCIDIN; 8 (4 SULFOPHENYL)THEOPHYLLINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE KINASE INHIBITOR; MORPHINE SULFATE; NALOXONE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE KINASE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEAT; MALE; MICE; MICE, INBRED STRAINS; PAIN THRESHOLD;

ANIMALIA;

EID: 0033040686     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00236-6     Document Type: Article

References (42)

1. Ahlijanian M.K., Takemori A.E. Effects of (-)-N6-(R-phenylisopropyl0-adenosine (PIA) on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112:1985;171-179.
2. Bannon A.W., Gunther K.L., Decker M.W. Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (±)-epibatidine. Pharmacol. Biochem. Behav. 51:1995;693-698.
3. Braas K.M., Newby A.C., Wilson V.S., Snyder S.H. Adenosine-containing neurons in the brain localized by immuno-cytochemistry. J. Neurosci. 6:1986;1952.
4. Britton, D. R.; Mikusa, J.; Lee, C. H.; Williams, M.; Kowaluk, E. A.: Adenosine kinase inhibition enhances kainic acid-induced increases in striatal adenosine. Soc. Neurosci. Abstr. 22:617.6; 1996.
5. 2 receptors in the rat spinal cord. J. Pharmacol. Exp. Ther. 242:1987;905-910.
6. Collier H.O.J., Dinneen L.C., Johnson C.A., Schneider C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmacol. Chemother. 32:1968;295-310.
7. Davies L.P., Jamieson D.D., Baird-Lambert J.A., Kazlauska R. Halogenated pyrrolopyrimidine analogues of adenosine from marine organisms. Pharmacological activities and potent inhibition of adenosine kinase Biochem. Pharmcol. 33:1984;347-355.
8. 2 receptors but have potent pharmacological activity in vivo. Biochem. Pharmcol. 35:1986;3021-3029.
9. Decker M.W., Bannon A.W., Buckley M.J., Kim D.J.B., Holladay M.W., Ryther K.B., Lin N.H., Wasicak J.T., Williams M., Arneric S.P. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. Eur. J. Pharmacol. 346:1998;23-33.
10. DeLander G.E., Mosberg H.I., Porreca F. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists. Dissociation from gastrointestinal effects in mice J. Pharmacol. Exp. Ther. 263:1992;1097-1104.
11. 2 adenosine receptors in spinal mechanisms of antinociception. Eur. J. Pharmacol. 139:1987;215-223.
12. DeLander G.E., Hopkins C.J. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J. Pharmacol. Exp. Ther. 239:1986;88-93.
13. Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;359-382 Wiley-Liss, Inc, New York.
14. Engler R.L. Consequences of activation and adenosine mediated inhibition of granulocytes during myocardical ischemia. Fed. Proc. 46:1987;2407-2412.
15. 3H]Nitrobenzylthioinosine binding sites in rat spinal cord and primary afferent neurons. Brain Res. 347:1985;321-327.
16. Golembiowska K., White T.D., Sawynok J. Adenosine kinase inhibitors augument release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307:1996;157-162.
17. 6-phenylisopropyladenosine. J. Pharm. Pharmacol. 35:1983;679-680.
18. Holmgren M., Hedner J., Mellstrand G., Nordberg G., Hedner T. Characterization of the antinociceptive effects of some adenosine analogs in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 334:1986;290-293.
19. Jarvis M.F. Psychomotor aspects of adenosine receptor activation. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;405-421 Wiley-Liss, Inc, New York.
20. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251:1989;888-893.
21. Jiang N., Kowaluk E.A., Lee C.H., Mazdiyansi H., Chopp M. Adenosine kinase inhibition protects brain against transient focal ischemia in rats. Eur. J. Pharmacol. 320:1997;131-137.
22. Jurna I. Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord. Nauyn Schmiedebergs Arch. Pharmacol. 327:1984;23-30.
23. Keddie J.R., Poucher S.M., Shaw G.R., Brooks R., Copllis M.G. In vivo characterization of ZM 241385, a selective adenosine A2A receptor antagonist. Eur. J. Pharmacol. 301:1996;107-113.
24. Keil G.J., DeLander G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine-and opioid agonist-induced antinociception in mice. Eur. J. Pharmacol. 271:1994;37-46.
25. Kowaluk E.A., Kohlhaas K.L., Daanen J., Lee C.H. Anticonvulsant effects of adenosine kinase inhibitors. Drug Dev. Res. 37:1996;190.
26. Kowaluk, E. A.; Bannon, A.; Gunther, K.; Kohlhaas, K.; Lynch, J.; Jarvis, M. F.: The effects of adenosine kinase (AK) inhibitors on acute thermal nociception. Soc. Neurosci. Abstr. 22:617.6; 1996.
27. Miller L.P., Jelovich L.A., Yao J., DaRe J., Ugarkar B., Foster A.C. Pre- and peristroke treatment with the adenosine kinase inhibitor, 5′-deoxyiodotubercidin, significantly reduces infarct volume after temporary occlusion of the middle cerebral artery in rats. Neurosci. Lett. 220:1996;73-76.
28. Murray T.F., Zhang G., Franklin P.H. Manipulation of endogenous adenosine affects seizure susceptibility. Drug. Dev. Res. 28:1993;410-415.
29. Paalzow G., Paalzow L. The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta Pharmacol. Toxicol. 32:1973;22-32.
30. Plone M.A., Emerich D.F., Linder M.D. Individual differences in the hotplate test and effects of habituation on sensitivity to morphine. Pain. 66:1996;265-270.
31. Plummer J.L., Cmielewski P.L., Gourlay G.K., Owne H., Cousins M.J. Assessment of antinociceptive drug effects in the presence of impaired motor performance. J. Pharmacol. Methods. 26:1991;79-87.
32. Poon A., Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor. Dependence on formalin concentration Eur. J. Pharmacol. 286:1995;177-184.
33. Post C. Antinociceptive effects in mice after intrathecal injection of 5′N-ethylcarboxamido adenosine. Neurosci. Lett. 51:1984;325-330.
34. Poucher S.M., Keddie J.R., Brooks R., Shaw G.R., McKillop D. Pharmacodynamics of ZM 241385, a potent A2A adenosine receptor antagonist, after enteric administration in rat, cat and dog. J. Pharm. Pharmacol. 48:1996;601-606.
35. Sawynok J. Purines and nociception. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;495-514 Wiley-Liss, Inc, New York.
36. Sawynok J., Espey M.J., Reid A. 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray. Neuropharmacol. 30:1991;871-877.
37. Sawynok J., Sweeny M.I., White T.D. Classification of adenosine receptors mediating antinociception in the rat spinal cord. Br. J. Pharmacol. 88:1986;923-930.
38. Vapaatalo H., Onken D., Neuvonen P.J., Westermann E. Stereospecificity in some central and circulatory effects of phenylisopropyladenosine (PIA). Arzneimittelforschung. 25:1975;407-410.
39. Wang B., Tang J., White P.F., Foster A.C., Grettengerger H.M., Kopcho J., Wender R.H. The effect of GP683, an adenosine kinase inhibitor, on the desflurane anesthetic requirement in dogs. Anesth. Analg. 85:1997;675-680.
40. Williams M., Burnstock G. Purinergic neurotransmission and neuromodulation. A historical perspective Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;3-26 Wiley-Liss, Inc, New York.
41. Yarbrough G.C., McGuffin-Clineschmidt J.C. In vivo behavioral assessment of central nervous system purinergic receptors. Eur. J. Pharmacol. 76:1981;137-144.
42. Zhang G., Franklin P.H., Murray T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264:1993;1415-1424.